Target intelligence / Profile preview

RNA, 7SL, cytoplasmic 630, pseudogene (RN7SL630P)

Target
RN7SL630P
Molecular classification
Other, Pseudogene, Non-coding RNA pseudogene
01

Overview

RN7SL630P (RNA, 7SL, cytoplasmic 630, pseudogene) is a non-coding RNA pseudogene found in the human genome[1][10]. It is a truncated, non-functional copy derived from the canonical 7SL RNA gene, which encodes an essential scaffold of the signal recognition particle (SRP)[7][9]. Most 7SL pseudogenes, including RN7SL630P, do not encode functional RNA or protein and are the result of retrotransposition events that inserted copies of the 7SL sequence into new genomic loci without retaining their original activity[9]. There is no evidence that RN7SL630P itself is expressed or has a regulatory or direct biological function, nor is it classified as a therapeutic target[1][10][9]. The related canonical gene (RN7SL1/7SL RNA) is well-studied, but this particular pseudogene does not have disease associations or known drug interactions. NOTES: - The entry is for a pseudogene, which by strict definition is *not* considered a protein, enzyme, receptor, or therapeutic target, and is generally not transcribed or functional[1][10][9]. - Most of the relevant literature describes *7SL RNA pseudogenes* collectively as non-functional, serving no direct, characterized biological or disease-related role, though some other pseudogenes can act in regulatory networks in some contexts[4][6]. No evidence specifically implicates RN7SL630P in such roles. Summary: RN7SL630P is a human pseudogene corresponding to 7SL RNA, with no known functional, biological, or therapeutic relevance, and should not be considered a therapeutic target[1][10][9].

Other names
RN7SL630PRNA, 7SL, cytoplasmic 630, pseudogene
02

Biological functions

Other (non-coding, no direct protein-coding function)
03

Disease associations

Other (no documented direct involvement; some 7SL pseudogenes are studied in cancer research, but not specifically RN7SL630P)

Beyond the preview

Go deeper on RNA, 7SL, cytoplasmic 630, pseudogene (RN7SL630P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SL, cytoplasmic 630, pseudogene (RN7SL630P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call